SUBSCRIBE
SUBSCRIBE

BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
207 Results
Year
Month
Day
Year
Month
Day
  • Drug Development
    Novavax Showcases Data from Expanding Vaccine Portfolio at IDWeek 2022
    Novavax, Inc. (Nasdaq: NVAX) will present new data from the Phase 3 PREVENT-19 trial evaluating its protein-based COVID-19 vaccine (NVX-CoV2373) as a booster in adults, including a breakdown by age and by booster dose interval (8 and 11 months) at IDWeek 2022, October 20 to 22, 2022.
    October 20, 2022
     · 
    6 min read
  • BioMidwest
    Cingulate to Present at LD Micro Investor Conference
    Cingulate Inc. (NASDAQ: CING) today announced that Cingulate Chairman & CEO Shane J. Schaffer will present at the LD Micro Main Event XV investor conference on October 26, 2022.
    October 20, 2022
     · 
    1 min read
  • BioCapital
    ABL Awarded NIH Contract for Continued Support of HIV Vaccine Development
    Advanced BioScience Laboratories announced it has been awarded a contract for “Preclinical and translational vaccine development for HIV and other candidate agents” by the Division of AIDS within the National Institute of Allergy and Infectious Disease of the National Institutes of Health.
    October 20, 2022
     · 
    3 min read
  • Primary Cell Culture Market Size to Hit USD 13.7 Billion by 2030
    According to Nova one advisor, the global Primary Cell Culture market size is expected to hit around USD 13.7 billion by 2030 from valued at USD 4.79 billion in 2021 and growing at a CAGR of 17.6% from 2022 to 2030.
    October 20, 2022
     · 
    10 min read
  • Embolotherapy Market Size, Growth, Demand, Opportunities & Forecast To 2030
    The global Embolotherapy market gathered revenue around USD 2.1 Billion in 2020 and market is set to grow USD 7.0 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 9.0% during the prediction period 2021 to 2027.
    October 20, 2022
     · 
    5 min read
  • Cell-Based Assays Market Size to Hit USD 34.8 Billion by 2030
    According to Nova one advisor, the global Cell-based Assays market size is expected to hit around USD 34.8 billion by 2030 from valued at USD 15.95 billion in 2021 and growing at a CAGR of 8.75% from 2022 to 2030
    October 20, 2022
     · 
    9 min read
  • Cell Separation Market Size to Hit USD 30.8 Billion by 2030
    According to Nova one advisor, the global Cell Separation market size is expected to hit around USD 30.8 billion by 2030 from valued at USD 7.6 billion in 2021 and growing at a CAGR of 19.8% from 2022 to 2030
    October 20, 2022
     · 
    9 min read
  • Cell Culture Market Estimated to Cross USD 60.27 BN by 2030
    The global Cell Culture market size was estimated at USD 21.05 billion in 2021 and is expected to surpass around USD 60.27 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 11.9% during the forecast period 2022 to 2030.
    October 20, 2022
     · 
    9 min read
  • Upstream Bioprocessing Market Size to Hit USD 22.9 BN by 2030
    According to Nova one advisor, the global Upstream Bioprocessing market size was valued at USD 10.60 billion in 2021 and is predicted to hit USD 22.9 billion by 2030 with a registered CAGR of 16.4% during the forecast period 2022 to 2030.
    October 20, 2022
     · 
    9 min read
  • 3D Cell Culture Market Size to Hit USD 6.8 Billion by 2030
    According to Nova one advisor, the global 3D Cell Culture market size is expected to hit around USD 6.8 billion by 2030 from valued at USD 2.9 billion in 2021 and growing at a CAGR of 11.40% from 2022 to 2030
    October 20, 2022
     · 
    5 min read